Life at the Johns Hopkins School of Medicine
In 2021 and 2023, the FDA approved Wegovy (semaglutide) and Zepbound (tirzapatide), respectively, for chronic weight management, along with increased physical activity and a reduced… Read More »New Published Study Maps Risks and Benefits Associated with Glucagon-Like Peptide 1 Receptor Agonist Use
Here’s how a group of passionate thinkers turned scholarly insights into therapies that could help millions of patients with heart failure.
Every day, 115 Americans are killed by opioid overdose. That this number is so strikingly high underlines the language of ‘“epidemics” and “emergencies” in politicians’… Read More »From Crisis to Consensus: Guidelines Aim to Reduce Over-Prescribing of Abused Drugs
In November 2015, the FDA approved the HIV-1 medication Genvoya, a once-daily pill containing fixed doses of the HIV drugs elvitegravir, cobicistat, emtricitabine and tenofovir… Read More »Once-Daily Combination Pills Offer More Than Convenience
It is no secret that weight loss is a major driver in American culture. In 2013, the U.S. weight loss market recorded a total market… Read More »Fighting Obesity: A National Health Issue